'For
the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Lal Pathlabs has increased 10.11% to Rs 538.9 crore compared to quarter ended Dec 2022. Operating profit margin has jumped from 23.09% to 26.09%, leading to 24.42% rise in operating profit to Rs 140.60 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 22.66% to 19.86%. Employee cost increased from 19.68% to 20.23%. Other expenses fell from 34.57% to 33.83%. Selling and administration expenses rose from 14.16% to 14.42%. Other income rose 74.29% to Rs 18.3 crore. PBIDT rose 28.66% to Rs 158.9 crore. Provision for interest fell 23.08% to Rs 7 crore.
PBDT rose 32.78% to Rs 151.9 crore. Provision for depreciation fell 5.01% to Rs 36 crore.
Profit before tax grew 51.50% to Rs 115.90 crore. Shar...
Pleaselogin & subscribe to view the full report.
More Reports
|
|